Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 StudyMyung‐Ju Ahn, Jaafar Bennouna, Nicolas Girard et al.|Journal of Clinical Oncology|2024Cited by 177
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre studyAntoine Desîlets, Arielle Elkrief, Félix Blanc‐Durand et al.|European Journal of Cancer|2020Cited by 78